Shanghai Sanyou Medical Co., Ltd. (688085.SS)
CNY 17.98
(2.92%)
CNY 17.98
(2.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 120.42 Million CNY | -55.7% |
| 2022 | 229.09 Million CNY | 12.29% |
| 2021 | 204.02 Million CNY | 56.48% |
| 2020 | 130.38 Million CNY | 19.24% |
| 2019 | 109.33 Million CNY | 59.96% |
| 2018 | 68.35 Million CNY | 730.79% |
| 2017 | 8.22 Million CNY | 625.28% |
| 2016 | 1.13 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.64 Million CNY | 149.69% |
| 2024 Q1 | -7.34 Million CNY | -123.74% |
| 2024 Q3 | 8.69 Million CNY | 172.23% |
| 2023 Q2 | 30.05 Million CNY | -30.25% |
| 2023 Q3 | 2.85 Million CNY | -90.5% |
| 2023 Q4 | 30.94 Million CNY | 983.2% |
| 2023 Q1 | 43.09 Million CNY | -48.93% |
| 2023 FY | 101.49 Million CNY | -55.7% |
| 2022 Q4 | 84.38 Million CNY | 133.71% |
| 2022 Q3 | 36.1 Million CNY | -32.0% |
| 2022 Q2 | 53.1 Million CNY | 38.64% |
| 2022 Q1 | 38.3 Million CNY | -55.63% |
| 2022 FY | 229.09 Million CNY | 12.29% |
| 2021 Q1 | 32.76 Million CNY | -19.07% |
| 2021 FY | 204.02 Million CNY | 56.48% |
| 2021 Q4 | 86.32 Million CNY | 98.22% |
| 2021 Q3 | 43.55 Million CNY | 5.24% |
| 2021 Q2 | 41.38 Million CNY | 26.29% |
| 2020 FY | 130.38 Million CNY | 19.24% |
| 2020 Q4 | 40.48 Million CNY | -10.3% |
| 2020 Q3 | 45.13 Million CNY | 47.49% |
| 2020 Q2 | 30.6 Million CNY | 116.11% |
| 2020 Q1 | 14.16 Million CNY | -48.45% |
| 2019 Q1 | 23.38 Million CNY | 14.18% |
| 2019 FY | 109.33 Million CNY | 59.96% |
| 2019 Q4 | 27.47 Million CNY | -1.57% |
| 2019 Q3 | 27.9 Million CNY | -8.73% |
| 2019 Q2 | 30.57 Million CNY | 30.78% |
| 2018 FY | 68.35 Million CNY | 730.79% |
| 2018 Q4 | 20.47 Million CNY | 0.0% |
| 2017 FY | 8.22 Million CNY | 625.28% |
| 2016 FY | 1.13 Million CNY | 0.0% |